Funding

Abingworth raises $356 million for late-stage pharma and biotech clinical programs

06-Nov-2023 By Liza Laws

Life sciences investment group and part of global investment firm Carlyle, Abingworth announced last week it had exceeded its $300 million target by $56 million.

PhaseV to push boundaries of machine learning with $15 million funding

25-Oct-2023 By Liza Laws

Advanced tech company, PhaseV, has raised $15 million in funding that it says it will use to ‘push the boundaries of machine learning for clinical trial optimization’.

Lokavant receives $8 million from investment giant, Mitsui to expand AI platform

05-Oct-2023 By Liza Laws

Clinical trial platform company, Lokavant, has received an $8 million strategic investment from global trading and investment giant, Mitsui & Co. Ltd.

Further investment for BDD Pharma after £2M funding round

17-Aug-2023 By Liza Laws

Integrated drug formulation and clinical trials company, BDD Pharma, will be expanding its phase appropriate development, manufacturing, and clinical testing services after a £2 million ($1.3 million) investment.

'Rapidly growing' Sterling Pharma gets undisclosed investment from GHO and Partners Group

25-May-2023 By Liza Laws

Global Healthcare Opportunities (GHO) Capital Partners LLP along with Partners Group has announced today (May 25) that it has invested an undisclosed amount in GHO portfolio company, Sterling Pharma Solutions.

Funding and study to support treatment to stop recurrent infection and ulcerative colitis

26-Apr-2023 By Liza Laws

A company developing a potential new category of oral therapies based on defined bacterial consortia has made two big announcements this week (April 25).

Powerful tool for capturing aneurysms from Viz.ai given funding and FDA clearance

23-Mar-2023 By Liza Laws

A powerful tool that could capture abdominal aortic aneurysms (AAA) and refer those at risk is the first to be given clearance by the US Food and Drink Administration (FDA).

BMS grants $10m in funding to address health disparity

20-Mar-2023 By Ben Hargreaves

The funding will be split between 17 US non-profit organizations this year, as the company reveals the broader progress it has made towards its long-term inclusion and diversity goals.

Cerevance secures $51M in funds to advance drugs for Parkinson's and other CNS diseases

14-Feb-2023 By Liza Laws

Series B financing of $51 million (€47 million) has closed a funding round for a Parkinson’s Disease drug advancing to a phase 2 clinical study.

Apnimed secures $80m in funding for sleep apnea drug

05-Jan-2023 By Ben Hargreaves

The company is advancing its lead candidate through to late-stage trials and announced it would use the funds to carry out two Phase III trials.

Cabinet Health raises $17m for sustainable packaging

03-Jan-2023 By Ben Hargreaves

The company aims to reduce the single-use plastics utilized in packaging across the pharma industry and has received funding to expand its business.

$14m raised in Series B will continue expansion of Experic’s headquarters

05-Dec-2022 By Maggie Lynch

Experic raises $14m in series B led by Harro Hofilger Packaging Systems and East Seattle Partners as CDMO sees growth in DPI product and clinical trial supply needs.

Vial secures $67m in funding for biotech-focused CRO

05-Dec-2022 By Ben Hargreaves

The CRO focuses its services towards biotechs by stating that they are cheaper and more efficient compared to rivals, and it was this principle that drew in General Catalyst to provide investment.

FDA requests total of $8.4b for fiscal year 2023 budget

29-Mar-2022 By Jenni Spinner

The agency's requested funding for FY 2023, nearly 34% higher than for FY 2022, calls for investments in public health modernization and pandemic preparation.

Inflammasome develops combo HIV/birth control implant

23-Aug-2021 By Jenni Spinner

Thanks in part to grants from the Gates Foundation, the company has come up with a bioerodible implant that combines HIV prevention and birth control.

Despite COVID-19, pharma R&D funding at all-time high: IQVIA

01-Jun-2021 By Jenni Spinner

According to the clinical research solutions firm, disruptions due to the pandemic did not stop the industry from fueling R&D at unprecedented levels.

Interline Therapeutics lands $92m to map, correct dysfunctional proteins

13-May-2021 By Jenni Spinner

The company reportedly will utilize the investment funding to expand its research platform, and to advance six of its preclinical therapeutic programs.

Immunomics firm reels in $14m to advance drug discovery

20-Apr-2021 By Jenni Spinner

ImmunoScape plans to use the investor funds to grow its Asia presence, expand into the US, and to further develop its Deep Immunomics platform technology.

Copado lands $96m in Series B funding to fuel life-sciences digital transformation

09-Mar-2021 By Jenni Spinner

The development technology firm plans to use the funds, sourced from a wide range of investors, to expand its dev-ops platform and expand its global reach.

Immunity-centric biotech firm lands $60m in Series A funding

11-Feb-2021 By Jenni Spinner

Immunai has secured a total of $80m in funding to develop and promote its efforts to harness machine learning to fuel advancement of novel immunotherapies.

Clinical informatics company raises $21.5m to fund tech

23-Dec-2020 By Jenni Spinner

Ovation.io will harness the funding to develop software and data products supporting drug discovery and development, creating diagnostics and more.

Rare-disease foundation backs regenerative research

03-Dec-2020 By Jenni Spinner

CureDuchenne is investing in and collaborating with Mesentech, a company with a prodrug platform designed to selectively deliver therapeutics to bone.

Medable lands $91m to fuel decentralized trial tech

03-Dec-2020 By Jenni Spinner

The Series C funding will be used to help accelerate the research industry’s adoption of decentralized and digital clinical trial technology.

NIAID awards $44m contract to advance COVID-19 drug

31-Aug-2020 By Jenni Spinner

The US institute has given a new contract to drug developer BioCryst to explore use of galidesivir in treatment of non-hospitalized COVID-19 patients.

Mission Bio raises $70m to help develop cancer therapies

17-Aug-2020 By Jenni Spinner

The company has landed $70m in Series C funding, with the purpose of accelerating development of cancer therapies with single-cell multiomics.

Reify Health raises $30m for clinical trial tech

13-Aug-2020 By Jenni Spinner

The cloud-based study technology firm has secured Series B funding to help develop and promote products like its clinical trial platform, StudyTeam.

Cancer Research UK backs Hummingbird’s cancer treatment development

13-Aug-2019 By Vassia Barba

Cancer Research UK to support the clinical development of Hummingbird’s investigative cancer treatment which has the potential to fight drug resistant tumours.

Funding for TriNetX totals $102m as the network expands globally

13-Mar-2019 By Maggie Lynch

TriNetX receives a total of $102m in a $40m Series D financing round as it continues to expand globally – looking to ‘spark a revolution,’ says CEO.

US budget tackles drug costs and generic competition

12-Mar-2019 By Maggie Lynch

The US Government released its fiscal year 2020 budget plan, which addressed affordable prescription drug costs through increased generic competition.